MicroRNAs modulate SARS ‐ CoV ‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2
Liver International · 2024
DOI: 10.1111/liv.16079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Rajendra Khanal und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Serine Endopeptidases, Angiotensin-Converting Enzyme 2, COVID-19, Hepatocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background and Aims Severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) preferentially infects the respiratory tract; however, several studies have implicated a multi‐organ involvement. Hepatic dysfunctions caused by SARS‐CoV‐2 infection have been increasingly recognized and described to correlate with disease severity. To elucidate molecular factors that could contribute towards hepatic infection, we concentrated on microRNAs (miRNAs), a class of small non‐coding RNAs that modulate various cellular processes and which are reported to be differentially regulated during liver injury. We aimed to study the infection of primary human hepatocytes (PHH) with SARS‐CoV‐2 and to evaluate the potential of miRNAs for modulating viral infection.
Methods
We analysed liver autopsies from a coronavirus disease 19 (COVID‐19)‐positive cohort for the presence of viral RNA using Nanopore sequencing. PHH were used for the infection with SARS‐CoV‐2. The candidate miRNAs targeting angiotensin converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) were identified using in silico approaches. To discover the potential regulatory mechanism, transfection experiments, qRT‐PCRs, western blots and luciferase reporter assays were performed.
Results
We could detect SARS‐CoV‐2 RNA in COVID‐19‐positive liver autopsies. We show that PHH express ACE2 and TMPRSS2 and can be readily infected with SARS‐CoV‐2, resulting in robust replication. Transfection of selected miRNA mimics reduced SARS‐CoV‐2 receptor expression and SARS‐CoV‐2 burden in PHH. In silico and biochemical analyses supported a potential direct binding of miR‐141‐3p to the SARS‐CoV‐2 genome.
Conclusion
We confirm that PHH are susceptible to SARS‐CoV‐2 infection and demonstrate selected miRNAs targeting SARS‐CoV‐2 entry factors and/or the viral genome reduce viral loads. These data provide novel insights into hepatic susceptibility to SARS‐CoV‐2 and associated dysfunctions in COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
- Research Group Liver Regeneration & RNA Therapeutics, REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.
- Department for Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
- Institute for Infection Research and Vaccine Development (IIRVD), Centre for Internal Medicine, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
- Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
- German Centre for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
ORCID-Profile: Natalie Heinen, Richard J P Brown
Förderung
- Bundesministerium für Bildung und Forschung
- Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
- Deutsche Forschungsgemeinschaft
- Deutscher Akademischer Austauschdienst
- Bundesministerium für Arbeit und Soziales
Zitieren
APA
Khanal, R., Heinen, N., Bogomolova, A., Meister, T. L., Herrmann, S. T., Westhoven, S., Nocke, M. K., Todt, D., Jockenhövel, F., Klein, I. M., Hartmann, L., Vondran, F. W. R., Steinmann, E., Zimmer, G., Ott, M., Brown, R. J. P., Sharma, A. D., & Pfaender, S. (2024). MicroRNAs modulate SARS ‐ CoV ‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2. Liver International. https://doi.org/10.1111/liv.16079
Vancouver
Khanal R, Heinen N, Bogomolova A, Meister TL, Herrmann ST, Westhoven S, et al. MicroRNAs modulate SARS ‐ CoV ‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2. Liver International. 2024. doi:10.1111/liv.16079
BibTeX
@article{Khanal2024,
author = {Khanal, Rajendra and Heinen, Natalie and Bogomolova, Alexandra and Meister, Toni L and Herrmann, Simon T and Westhoven, Saskia and Nocke, Maximilian K and Todt, Daniel and Jockenhövel, Freya and Klein, Isabel M and Hartmann, Laura and Vondran, Florian W R and Steinmann, Eike and Zimmer, Gert and Ott, Michael and Brown, Richard J P and Sharma, Amar Deep and Pfaender, Stephanie},
title = {MicroRNAs modulate SARS ‐ CoV ‐2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16079}
}
EUVIMED